Dissolving microneedles loaded with nimodipine for prevention of sleep disorders at a high altitude
Sleep disorders are one of the most common acute reactions on the plateau, which can cause serious complications. However, there is no effective and safe treatment currently available. Nimodipine (NMD) is a dihydropyridine calcium channel blocker with neuroprotective and vasodilating activity, mainly used for the treatment of ischemic brain injury. Commercial oral or injectable NMD formulations are not a good option for central neuron diseases due to their poor brain delivery. In this study, nimodipine dissolving microneedles (NDMNs) were prepared for the prevention of sleep disorders caused by hypoxia. NDMNs were composed of NMD and polyvinyl pyrrolidone (PVP) K90 with a conical morphology and high rigidity. After administration of NDMNs on the back neck of mice, the concentration of NMD in the brain was significantly higher than that of oral medication as was confirmed by the fluorescent imaging on mouse models. NDMNs enhanced cognitive function, alleviated oxidative stress, and improved the sleep quality of mice with high-altitude sleep disorders. The blockage of calcium ion overloading may be an important modulation mechanism. NDMNs are a promising and user-friendly formulation for the prevention of high-altitude sleep disorders.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Pharmaceutical development and technology - (2024) vom: 16. Apr., Seite 1-42 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Chunqing [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
High altitude |
|---|
| Anmerkungen: |
Date Revised 16.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1080/10837450.2024.2342965 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371154251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371154251 | ||
| 003 | DE-627 | ||
| 005 | 20240417233219.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240417s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10837450.2024.2342965 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1378.xml |
| 035 | |a (DE-627)NLM371154251 | ||
| 035 | |a (NLM)38626316 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Chunqing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dissolving microneedles loaded with nimodipine for prevention of sleep disorders at a high altitude |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Sleep disorders are one of the most common acute reactions on the plateau, which can cause serious complications. However, there is no effective and safe treatment currently available. Nimodipine (NMD) is a dihydropyridine calcium channel blocker with neuroprotective and vasodilating activity, mainly used for the treatment of ischemic brain injury. Commercial oral or injectable NMD formulations are not a good option for central neuron diseases due to their poor brain delivery. In this study, nimodipine dissolving microneedles (NDMNs) were prepared for the prevention of sleep disorders caused by hypoxia. NDMNs were composed of NMD and polyvinyl pyrrolidone (PVP) K90 with a conical morphology and high rigidity. After administration of NDMNs on the back neck of mice, the concentration of NMD in the brain was significantly higher than that of oral medication as was confirmed by the fluorescent imaging on mouse models. NDMNs enhanced cognitive function, alleviated oxidative stress, and improved the sleep quality of mice with high-altitude sleep disorders. The blockage of calcium ion overloading may be an important modulation mechanism. NDMNs are a promising and user-friendly formulation for the prevention of high-altitude sleep disorders | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a High altitude | |
| 650 | 4 | |a Microneedle | |
| 650 | 4 | |a Nimodipine | |
| 650 | 4 | |a Sleep disorder | |
| 700 | 1 | |a Huang, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Ziyan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yizhi |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Meng |e verfasserin |4 aut | |
| 700 | 1 | |a Du, Shumin |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Xingshuang |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Yanping |e verfasserin |4 aut | |
| 700 | 1 | |a Chi, Qiang |e verfasserin |4 aut | |
| 700 | 1 | |a Zhuang, Xiaomei |e verfasserin |4 aut | |
| 700 | 1 | |a Lina, Du |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Yiguan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d 1998 |g (2024) vom: 16. Apr., Seite 1-42 |w (DE-627)NLM094740194 |x 1097-9867 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:16 |g month:04 |g pages:1-42 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10837450.2024.2342965 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 16 |c 04 |h 1-42 | ||